EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect

Jerome Clatot iD, Hubert Monnerie iD, Axel Panzer iD, Konrad Platzer iD, Ethan M Goldberg iD

Journal of General Physiology · 07.09.2026 · 158 (5)

DOI: 10.1085/jgp.202513962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Physiology, online erschienen am 25.06.2026. Verfasst von Jerome Clatot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Shaw Potassium Channels, Epilepsy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Lauren Arena Fund, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in KCNC1 encoding the voltage-gated potassium (K+) channel subunit KV3.1 are an emerging cause of a spectrum of neurological disease including developmental delay/intellectual disability, ataxia, myoclonus, and epilepsy, including progressive myoclonus epilepsy and developmental and epileptic encephalopathy. Here, we report novel biophysical properties of a recurrent de novo missense variant in KCNC1 c.1196C>T (p.Thr399Met) associated with epilepsy, mild developmental delay, and nonprogressive ataxia. The variant is localized to the highly conserved pore region of the channel, and voltage-clamp electrophysiological recording demonstrated a complete loss of function, as seen in more severe forms of KCNC1-related disorders. When expressed with wild-type (WT) to mimic the heterozygous state of the variant as would occur in a disease context, current density was not markedly reduced; however, resulting currents displayed a ∼20 mV hyperpolarizing shift of the voltage dependence of activation along with slowed deactivation kinetics, consistent with gain of function. In order to better understand this “dominant-positive effect” exerted on the WT channel, we co-expressed the KV3.1 p.Thr399Met variant with the recurrent p.Ala421Val variant known to act via loss of function with near-complete absence of current and associated with severe KCNC1-related disease. Co-expression of the two nonfunctioning variants led to a mild rescue of K+ current compared with the KCNC1-p.Ala421Val variant alone, further supporting a dominant-positive effect. Both KCNC1-p.Thr399Met and p.Ala421Val displayed trafficking deficiency. These results suggest that inclusion of the p.Thr399Met variant in heterotetrameric KV3 channels alters the gating kinetics of WT channel subunits, and highlight the unique features of this variant. The apparent complete loss of function of the p.Thr399Met variant when expressed alone is inconsistent with the relatively mild clinical presentation of the patient, subsequently explained via the “dominant-positive” action when combined with WT subunits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shaw Potassium ChannelsEpilepsyHumansAnimalsMutation, Missense

Substanzen

Shaw Potassium ChannelsKCNC1 protein, human

Autor:innen und Institutionen

  • Division of Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • The Epilepsy Neurogenetics Initiative, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • The Center for Brain Development, Genetics, and Engineering (BRIDGE), The Children's Hospital of Philadelphia , Philadelphia, PA, USA.
  • DRK Kliniken Berlin Westend, Epilepsy Center/Pediatric Neurology , Berlin, Germany.
  • Institute of Human Genetics, University of Leipzig Medical Center , Leipzig, Germany.
  • Department of Neurology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

ORCID-Profile: Jerome Clatot, Hubert Monnerie, Axel Panzer, Konrad Platzer, Ethan M Goldberg

Förderung

  • NINDS NIH HHS
  • Lauren Arena Fund
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Clatot, J., Monnerie, H., Panzer, A., Platzer, K., & Goldberg, E. M. (2026). An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect. Journal of General Physiology, 158(5). https://doi.org/10.1085/jgp.202513962

Vancouver

Clatot J, Monnerie H, Panzer A, Platzer K, Goldberg EM. An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect. Journal of General Physiology. 2026;158(5). doi:10.1085/jgp.202513962

BibTeX
@article{Clatot2026,
  author = {Clatot, Jerome and Monnerie, Hubert and Panzer, Axel and Platzer, Konrad and Goldberg, Ethan M},
  title = {An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect},
  journal = {Journal of General Physiology},
  year = {2026},
  volume = {158},
  number = {5},
  doi = {10.1085/jgp.202513962}
}
Kostenlos starten →